Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · IEX Real-Time Price · USD
29.32
+0.39 (1.35%)
Apr 26, 2024, 4:00 PM EDT - Market closed

HRMY Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019
Market Capitalization
1,6641,8923,2682,4932,057-
Market Cap Growth
--42.12%31.09%21.23%--
Enterprise Value
1,5051,7323,1372,4512,02273
PE Ratio
13.7714.6818.0172.07-32.21-
PS Ratio
2.863.257.478.1612.87-
PB Ratio
3.564.058.1113.3721.16-
P/FCF Ratio
7.608.6422.6525.37-688.50-
P/OCF Ratio
7.598.6222.6225.30-688.96-
EV/Sales Ratio
2.592.987.168.0212.6612.26
EV/EBITDA Ratio
6.797.8221.3630.461336.52-0.52
EV/EBIT Ratio
7.638.7825.4039.77-231.79-0.50
EV/FCF Ratio
6.877.9121.7424.94-676.99-0.97
Debt / Equity Ratio
0.410.410.481.032.00-0.23
Debt / EBITDA Ratio
0.870.871.302.39128.39-0.69
Debt / FCF Ratio
0.880.881.331.95-65.03-1.30
Quick Ratio
2.612.614.795.011.861.44
Current Ratio
2.752.755.075.291.951.58
Asset Turnover
0.760.760.770.800.600.06
Interest Coverage
8.308.306.572.55-0.31-24.03
Return on Equity (ROE)
27.50%27.50%60.10%24.20%39.20%56.30%
Return on Assets (ROA)
16.80%16.80%31.70%9.10%-23.90%-191.00%
Return on Capital (ROIC)
21.60%21.60%35.04%21.38%5.83%44.91%
Earnings Yield
7.74%6.81%5.55%1.39%-3.10%-
FCF Yield
13.16%11.58%4.41%3.94%-0.15%-
Buyback Yield / Dilution
1.19%1.19%-3.20%-129.72%-231.37%12.19%
Total Shareholder Return
1.19%1.19%-3.20%-129.72%-231.37%12.19%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).